Angela Hwang - May 10, 2023 Form 4 Insider Report for PFIZER INC (PFE)

Role
President, Global Biopharma
Signature
Susan E. Grant, by power of atty., for Angela Hwang
Stock symbol
PFE
Transactions as of
May 10, 2023
Transactions value $
$1,300,017
Form type
4
Date filed
5/11/2023, 06:46 PM
Previous filing
May 5, 2023
Next filing
May 3, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Phantom Stock Units SSP Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities $1.3M +33.9K +96.7% $38.30 69K May 10, 2023 Common Stock 33.9K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents one phantom share of common stock.
F2 This transaction constitutes an intra-plan transfer to acquire Pfizer stock units in the Pfizer stock unit fund under the Pfizer Inc. Supplemental Savings Plan.
F3 These units, which were acquired pursuant to the Pfizer Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.